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Gas chromatography (GC) is a gold standard technique used in forensic laboratories, including for the characterization of 
counterfeit medicines. When coupled simultaneously to flame ionization (FID) and mass detector (MS) allow the 
identification and quantification of medicines and drugs employing a single method, besides permitting the application of 
chemometric tools for forensic intelligence purposes. Here is presented a pilot study that developed and applied a simple 
qualitative method for the analysis of irregular medicines using a simple extraction procedure followed by GC-FID/MS 
analysis, with application of chemometric tools. The main purpose was to identify similarities between the all compounds 
detected in the irregular medicines allowing the traceability of illicit producers with the creation of a common data base. 
Seized medicines obtained from different producers were extracted with methanol and submitted to ultrasound and 
centrifugation. 1mL was then injected into the GC through simultaneous detection by FID and MS. Through the analyses 
it was verified that different producers of counterfeit medicines labeled as Sibutramine, added a mixture of Caffeine and 
Benzocaine to its formulation, respecting the same ratio of 2.2:1. Hierarchical Cluster Analysis (HCA) was able to 
confirm these results, showing the presence of both falsifications in the same cluster, representing the best tool to identify 
similar characteristics among the samples. Other interesting finding was the use of Fluoxetine as a falsification of 
counterfeit medicines labeled as Sibutramine and Diethylpropion. Another seized sample labeled as “Nobésio Forte”, 
marketed as a mix of stimulants, showed mainly Caffeine and Lidocaine in its formulation. The pilot project applied 
primarily to 45 samples of counterfeit medicines containing amphetamine-type stimulants and antidepressants, showed 
the capability of perform the chemical profiling of counterfeit medicines in the solid form - powder, capsules and tablets. 
Further analysis can be performed for different types of medicines in solid form using the developed method, allowing 
the construction of a single database to perform the chemical profiling of counterfeit medicines, helping forensic 
intelligence to track the illicit producers. 
 






Investigations and analyses of counterfeit medicines 
have been rising in recent years following the growing of 
medicines falsification worldwide [1,2]. Chemical 
profiling of counterfeit medicines plays an important 
role in forensic intelligence in order to identify the 
different types of falsification and illicit producers [3]. 
Several methods have been employed for chemical 
analysis of counterfeit medicines, being most common 
the chromatographic and spectroscopic [2]. The use of 
multivariate statistical analysis combined with results 
obtained by analytical techniques is a valuable trend for 
chemical profiling. These combinations bring relevant 
information of medicines and drugs, by focusing in 
similarities and dissimilarities of active ingredients, 
excipients, residual solvents and etc. [4,5]. Similarities in 
the chemical constitution can be shown using 
exploratory tools such as Principal Component Analysis 
(PCA) and Hierarchical Cluster Analysis (HCA), 
indicating the same producer for samples from different 
apprehensions, or even different medicines, helping 
forensic intelligence [6]. Analysis of excipients likewise 
can raise important information about the counterfeit 
medicines production [5], highlighting correlations 
between different samples, which can use the same 
formula or mixture of components for the production of 
distinct medicines, as was identified for counterfeit 
medicines of Cialis and Viagra, reported by Ortiz et al, 
2013 [7]. 
Here was proposed a pilot project through gas 
chromatography with simultaneous analysis by flame 
ionization and mass spectrometer detector, followed by 
application of chemometric tools of HCA and PCA, to 
determine similarities between irregular medicines 
seized by Brazilian Federal Police of Rio Grande do Sul. 
The main purpose was to develop and implement a 
simple method of GC to identify a standard mixture of 
substances used to produce different counterfeit 
medicines in solid form, permitting its traceability.  
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45 solid samples of counterfeit medicines (tablets and 
capsules) from different batches were seized in the South 
of Brazil, in 2017, by Brazilian Federal Police (Porto 
Alegre, Rio Grande do Sul). The counterfeit medicines 
comprised mainly amphetamine-type-stimulants, such as 
Sibutramine, Fenproporex, Ritalin, Mazindol and 
Amfepramone; antidepressants (Fluoxetine), and some 
non-identified formulas like “Nobésio Forte” (Table 1). 
 
Table 1. Irregular medicines seized by Brazilian Federal 
Police of Rio Grande do Sul. 




First, tablets and capsules were individually weighted, in 
triplicate. Then, the tablets had their shell removed (if 
present) and the capsules were opened, had their content 
removed, followed by homogenization. The mixture 
powder of each medicine was weighted considering 10% 
of its total weight, in triplicate. The powder was then 
transferred to a polypropylene tube in which 5 mL of 
Methanol was added. The tubes were submitted to a 
vortex for 1 min, added to ultrasound for 10 min and 
centrifuged at 3000 r.p.m. for 5 minutes. 1 mL of 
supernatant was added to a 2 mL vial and transferred to 
the chromatograph for automatic injection. The volume 
of injection was 1 µL. 
 
Gas Chromatography (CG) 
 
The analyses were conducted using a GC-MS/FID 
(7890B/5977B) Agilent Technologies (CA, USA) 
equipped a Combipal CTC Analytics (Basel, 
Switzerland), and a two-way splitter to connect the GC 
column to mass spectrometer (MS) and flame ionization 
(FID) detectors. For chromatographic separation was 
employed a DB5-MS column (30m x 0,25mm x 
0,25µm). Were also used connecting capillaries without 
a stationary phase, with dimensions of 0.10 mm I.D., 1 
m long to MS; and 0.15 mm and 1.62 m long to FID. 
The final proportion MS:FID was 29:71. Mass detector 
was operated using 70-eV (EI) with a source 
temperature, quadrupole and interface of 230°C, 150 °C 
and 280 °C respectively. The analyses were performed in 
Scan mode ranging 40 - 550 m/z. The injector was set at 
280 °C using a split of 1:20. Oven temperature was 
programmed to starting at 100 °C to 280 °C with an 
increase of 20 °C/min, and held for 2 min; then starting 
at 280 °C to 310 °C with at an increase of 5 °C/min, and 
held for 17 min. The total run was 39 min. Ultrapure 
helium was the carrier gas at 1 mL/min for DB-5MS; 1.5 
mL/min for MS connecting capillary and 3.858 mL/min 
for FID connecting capillary. FID detector temperature 
was set at 300 °C. Synthetic air and Hydrogen at 300 and 
30 mL/min respectively, were used to keep the flame; 





Determination of similarities between seized medicines 
and assessment of additional information from chemical 
analysis was employed by using Hierarchical Cluster 
Analysis (HCA) PASW Statistics®, version 18 ® and 
Principal Component Analysis (RStudio, 
Version 1.2.5033, package stats). 
 
Results and Discussion 
 
The seized medicines analyzed comprised amphetamine-
type stimulants from different producers such as Pharma 
Arte®, Gadol®, Aché®, Novartis®, Phidia Pharma® and 
some unidentified companies, along with antidepressants 
from Biosintética® and Genom® (Figure 1). FID data 
was used for multivariate statistical analysis considering 
the peak areas of all the compounds identified in the 
chromatographic run from each medicine, and their 
respective retention times. In order to standardize which 
peaks would be considered in the chromatogram, a 
cutoff was applied to the peaks that presented a 
minimum of 0.02% of the largest peak area in the 
chromatogram. Simultaneously, the MS results were 
processed in order to identify the compounds, using a 
full scan analysis (40-550 m/z) and considering the 
comparison with NIST library, literature data and the 
deconvolution of selected peaks. 
By HCA it is possible to identify similarities between the 
seized samples through its proximity in the experimental 
space [8]. The proximity between the samples leads the 
formation of distinct clusters (groups), which are 
interpreted by analyzing a Dendrogram. After HCA 
analysis using FID data it was possible to identify the 
formation of seven clusters, as can be seen in Figure 2. 
Cluster G had the sample of Ritalin® which did not show 
the correspondent API Methylphenidate. However, 
Ritalin showed peaks of excipients degradation at 8.40, 
9.00, 9.90 and 13.01 min. 
Medicines API Manufacturer 
Solid oral 
dosage form 
Fenproporex Fenproporex Unidentified  Capsule 
Sibugras Sibutramine Unidentified Capsule 
Sibutramina Sibutramine Unidentified Capsule 
Nobésio 
Forte 
Unidentified Unidentified Tablet 
Dimagrir Mazindol Gadol® Capsule 
Reductil Sibutramine Phidia 
Pharma® 
Capsule 
Ritaline Methylphenidate Novartis® Tablet 
Dualid Diethylpropion Aché® Capsule 
Biomag Sibutramine Aché® Capsule 
Fluoxetina Fluoxetine Biosintética® Capsule 
Fluoxetina Fluoxetine Genom® Capsule 
 





Figure 1. Pictures of medicines seized by Brazilian Federal 
Police of Rio Grande do Sul. a) Fenproporex; b) Sibutramine; 
c) Nobésio Forte; d) Dimagrir; e) Reductil; f) Fluoxetine 
(Biosintética); g) Ritalin; h) Fluoxetine (Genom); i) Biomag 
and j) Dualid. 
 
Those retention times were not encountered in any of the 
other medicines, justifying the superior distance from the 
other groups. Cluster F, E and D were also formed for 
one type of medicine each, containing Dimagrir®, 
Dualid® and Nobésio Forte®, respectively. Dimagrir® 
showed the correspondent API Mazindol at 17.7 min. 
Dualid® revealed the presence of Fluoxetine instead of 
Diethylpropion at a RT of 13.63 min. Nobésio Forte®, a 
mixed formula without manufacturer identification, 
showed as main compounds Caffeine at 13.65 min and 
Lidocaine at 13.95 min, respectively. 
The most interesting result was encountered in Cluster C 
with samples of Sibugras® and Sibutramine®, seized 
medicines from unidentified producers that presented the 
combination of Benzocaine at 11.898 -11.901 min and 
Caffeine at 13.65-13.652 min, instead of presenting 
Sibutramine as the API. It was also verified the 
proportion of addition of these compounds in both seized 
medicines, calculating the ratio between the two 
compounds. The results showed the same proportion of 
2.2:1 (Benzocaine:Caffeine) in Sibugras® and 
Sibutramine®. This preliminary result could indicate the 
ability of the method of grouping the samples using the 
applied criteria, beyond the focus on the API, identifying 
a mixture of substances that could be employing by the 
producers. Cluster C also showed the presence of 
Fluoxetine from Genom® and Biosintética®. These 
samples remained at cluster C due to their similarity in 
the retention times (RT), since Fluoxetine showed a RT 
of 13.63 min closed to caffeine at 13.65 min. The sample 
Biomag® was also present in Cluster C and however, can 
be easily seen that a lower Dendrogram cutoff at 4.9 (red 
line) could separate it in another cluster, not applied here 
due to the Parsimonious principle [6]. This sample 
showed a degradation product at 15.7 min, without any 
correspondence with the API Sibutramine. Cluster B, 
close related to Cluster C was formed by the sample 
Reductil® and did not grouped with Cluster B due to the 
presence of a degradation product at 13.97 min derived 
from excipient degradation, beyond the peak at 13.63 
min, attributed to Fluoxetine, instead of the 
correspondent API Sibutramine. Cluster A was formed 




Figure 2. Dendrogram of 45 counterfeit medicines analyzed by 
GC-MS/FID in triplicate. 
 
PCA showed the formation of four groups (Figure 3). 
Group I which consisted only of Ritalin®. Group II 
which presented Dualid® and Group III which contained 
Dimagrir®, showing similar results to those obtained by 
HCA for the 3 samples, which also remained in 
separated clusters in HCA. However, group IV was 
composed by the rest of the seized samples with few 
non-zero values, that means, few compounds identified 
by the RT variable. Therefore, samples with non-zero 
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value only in a restricted number of variables does not 
present significant distinction among other samples, 
explaining the formation of group IV. So, despite also 
showing the presence of the samples Sibugras® and 
Sibutramine® in the same group, the results encountered 
by PCA analysis did not showed significant information. 
Thus, considering the data base constructed with FID 
results and the main purpose of identify similar 
characteristics obtained from all the substances detected 
in the chromatogram, HCA showed better results when 
compared to PCA, even when applied to a small number 
of samples. Both medicines, Sibutramine® and 
Sibugras®, showed peak areas in the same proportion 
and RT, indicating a high probability of production of 
both seized medicines using an equivalent formula, as 
was already detected in other studies with counterfeit 
medicines of Cialis and Viagra [7]. This information can 
be useful for forensic intelligence in order to track the 
illicit producers of these counterfeit medicines and can 
be further applied to other types of seized medicines that 
present a solid dosage form, contributing for the 
formation of a common database for police intelligence. 
The samples analyzed showed degradation products, the 
API and mixtures of substances employed as a common 
formula for different medicines. Different from the usual 
methods, which search specifically for the API of each 
medicine to group the samples, the aim here was to 
obtain all the compounds present in the chromatograms 
and use these values to construct a database, targeting 
chemometric analysis. So, the purpose was not to 
compare the medicines against their authentic samples 
and find their API, but use the same extraction process 
and GC method for different solid materials, allowing 
the identification of similar formulas that could indicate 
a common origin between the seized medicines. 
After the analysis, it was also noted that Fluoxetine, a 
Serotonin-Selective Reuptake Inhibitor used as 
antidepressant [9], it’s being employed to falsify seized 
samples labeled as Sibutramine and Diethylpropion. 
Considering the results of this study and comparing with 
other studies performed by our research group [10], the 
target of falsification for the amphetamine-type 
stimulants now seems to be Sibutramine instead of 
Fenproporex. Since 2011, Sibutramine it’s the only 
anorectic stimulant commercialized in Brazil according 
to National Health Surveillance Agency (ANVISA). 
[11]. Concerning the samples of “Nobésio Forte”, which 
presented an indicative use for increase alertness in 
informal Brazilian market, especially for truck drivers   
[10,12], the analyses showed the presence of Caffeine 
and Lidocaine, instead of any type of amphetamine-type 
stimulants such as, fenproporex, sibutramine or 
diethylpropion. Both anesthetics are commonly 
employed as adulterants in the production of cocaine, 
mainly to enhance and simulate its effects [13,14]. 
 
 
Figure 3. PCA analysis of the 45 counterfeit medicines 




The method using a simple extraction procedure 
followed by the analysis through GC and the 
simultaneous detection by FID and MS, was able to 
perform the chemical profiling of the counterfeit 
medicines analyzed. Thus, it can be further applied in the 
routine of forensic laboratories to analyze distinct seized 
solid materials - medicines and drugs - enabling the 
construction of a single database. Thus, allows the 
correlation of data from all seized samples by employing 
HCA as a complementary approach to the traditional 
applications of GC. In this case, the conditions for using 
the developed method is to detect all the constituents 
present in the chromatogram of seized solid samples 
following the criteria established – beyond the focus on 
the API, drafting a different perspective for chemical 
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